calendar
25,090 catalysts · 5,445 approval · 5,000 device 510k · 4,728 grant · 3,126 8k filing · 2,000 device pma · 2,000 device recall
25,090 catalysts · 5,445 approval · 5,000 device 510k · 4,728 grant · 3,126 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: GENMAB US, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: PYROS PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: UCB INC. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL
Sponsor: PADAGIS US. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MANKIND PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL
Sponsor: BRAEBURN. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: CELLTRION. Form: INJECTABLE. Route: INJECTION
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: HERON THERAPS INC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: SUBLINGUAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: SUBLINGUAL
Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: SUBLINGUAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: SUBLINGUAL
Sponsor: BARR. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL